DrugPatentWatch Database Preview
Finafloxacin - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic sources for finafloxacin and what is the scope of patent protection?
Finafloxacin
is the generic ingredient in one branded drug marketed by Merlion Pharms Gmbh and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Finafloxacin has thirty-nine patent family members in eighteen countries.
Summary for finafloxacin
International Patents: | 39 |
US Patents: | 3 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Bulk Api Vendors: | 25 |
Clinical Trials: | 7 |
Patent Applications: | 16 |
DailyMed Link: | finafloxacin at DailyMed |
Recent Clinical Trials for finafloxacin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
MerLion Pharmaceuticals GmbH | Phase 2 |
MerLion Pharmaceuticals GmbH | Phase 1 |
Synonyms for finafloxacin
(-)-8-Cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-4-oxo-1 |
(-)-8-Cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
209342-40-5 |
3-Quinolinecarboxylic acid,8-cyano-1-cyclopropyl-6-fluoro-7-[(4as,7as)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo- |
7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid,hydrochloride |
8-cyano-1-cyclopropyl-6-fluoro-7-((1S,6S)-2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid |
8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
AC-29291 |
AKOS027422437 |
BAY35-3377,finafloxacin hydrochloride |
BCP23882 |
CHEBI:85176 |
CHEMBL1908370 |
CS-5557 |
D10575 |
D26OSN9Q4R |
DB09047 |
DTXSID10175096 |
Finafloxacin (INN) |
Finafloxacin [INN] |
FYMHQCNFKNMJAV-HOTGVXAUSA-N |
gastrochinolon |
gastroquinolone |
HY-13451 |
QCR-30 |
SB17124 |
SCHEMBL1002869 |
UNII-D26OSN9Q4R |
Xtoro |
Xtoro (TN) |
Xtoro;7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid |
ZINC3985346 |
US Patents and Regulatory Information for finafloxacin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for finafloxacin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | Start Trial | Start Trial |
Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for finafloxacin
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2016500079 | Start Trial |
China | 109908081 | Start Trial |
Russian Federation | 2693476 | Start Trial |
Brazil | 112015010927 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |